Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 509-514

  Masumoto, Nobuo ^a   Fujii, Takuma ^a   Ishikawa, Mitsuya ^a   Mukai, Makio ^a   Ono, Akiko ^a   Iwata, Takashi ^a   Kubushiro, Kaneyuki ^a   Nozawa, Shiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical neoplasia; HPV typing; Human papillomavirus 16

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OUTPATIENT; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZATION; SCHOOL CHILD; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS TYPING;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; JAPAN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 3543087359     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.011     Document Type: Article

References (31)

1. Burk R.D., Ho G.Y., Beardsley L., Lempa M., Peters M., Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J. Infect. Dis. 174:1996;679-689
2. Evander M., Edlund K., Gustafsson A., et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J. Infect. Dis. 171:1995;1026-1030
3. Karlsson R., Jonsson M., Edlund K., et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm. Dis. 22:1995;119-127
4. Fairley C.K., Chen S., Ugoni A., Tabrizi S.N., Forbes A., Garland S.M. Human papillomavirus infection and its relationship to recent and distant sexual partners. Obstet. Gynecol. 84:1994;755-759
5. Bauer H.M., Ting Y., Greer C.E., et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 265:1991;472-477
6. Woodman C.B., Collins S., Winter H., et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 357:2001;1831-1836
7. Josefsson A.M., Magnusson P.K., Ylitalo N., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 355:2000;2189-2193
8. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:1998;423-428
9. Melkert P.W., Hopman E., van den Brule A.J., et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int. J. Cancer. 53:1993;919-923
10. Burk R.D., Kelly P., Feldman J., et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm. Dis. 23:1996;333-341
11. Sasagawa T., Basha W., Yamazaki H., Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol. Biomarkers Prev. 10:2001;45-52
12. Masumoto N., Fujii T., Ishikawa M., et al. Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br. J. Cancer. 88:2003;1883-1888
13. Yoshikawa H., Nagata C., Noda K., et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br. J. Cancer. 80:1999;621-624
14. Fujii T., Tsukazaki K., Kiguchi K., Kubushiro K., Yajima M., Nozawa S. The major E6/E7 transcript of HPV-16 in exfoliated cells from cervical neoplasia patients. Gynecol. Oncol. 58:1995;210-215
15. Nakagawa H., Sugano K., Fujii T., Kubushiro K., Tsukazaki K., Nozawa S. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis. Anticancer Res. 22:2002;1655-1660
16. Yoshikawa H., Kawana T., Kitagawa K., Mizuno M., Yoshikura H., Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res. 82:1991;524-531
17. Herrero R., Hildesheim A., Bratti C., et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:2000;464-474
18. Bontkes H.J., de Gruijl T.D., Walboomers J.M., et al. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J. Gen. Virol. 80(Pt 2):1999;409-417
19. de Gruijl T.D., Bontkes H.J., Walboomers J.M., et al. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J. Gen. Virol. 80(Pt. 2):1999;399-408
20. Palefsky J.M., Minkoff H., Kalish L.A., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl. Cancer Inst. 91:1999;226-236
21. Munoz N., Kato I., Bosch F.X., et al. Risk factors for HPV DNA detection in middle-aged women. Sex Transm. Dis. 23:1996;504-510
22. Expanded use of HPV test. FDA Consum. 37:2003;4
23. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:1995;796-802
24. Brinton L.A., Fraumeni J.F. Jr. Epidemiology of uterine cervical cancer. J. Chronic Dis. 39:1986;1051-1065
25. Brisson J., Bairati I., Morin C., et al. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J. Infect. Dis. 173:1996;794-799
26. Hinchliffe S.A., van Velzen D., Korporaal H., Kok P.L., Boon M.E. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br. J. Cancer. 72:1995;943-945
27. Rosenfeld W.D., Rose E., Vermund S.H., Schreiber K., Burk R.D. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. J. Pediatr. 121:1992;307-311
28. Hsing A.W., Schiffman M., Zhang T., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 170:1994;498
29. de Villiers E.M., Wagner D., Schneider A., et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol. Oncol. 44:1992;33-39
30. Hildesheim A., Schiffman M.H., Gravitt P.E., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:1994;235-240
31. Romney S.L., Ho G.Y., Palan P.R., et al. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol. Oncol. 65:1997;483-492